Immunization of the HIV infected traveller
Arginine methylation of the HIV-1 nucleocapsid protein results in its diminished function
Routine HIV-1 genotyping as a tool to identify dual infections
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression
Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients
Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART
The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda
Voluntary counselling and testing: uptake, impact on sexual behaviour, and HIV incidence in a rural Zimbabwean cohort
Highly efficient HIV transmission to young women in South Africa
Monitoring death and cancer in children born to HIV-infected women in England and Wales: use of HIV surveillance and national routine data
Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection
Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients
Mortality after myocardial infarction in HIV-infected patients who have initiated HAART
Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART
Treatment resistance after sequential interruption of a non-nucleoside reverse transcriptase inhibitor-based regimen
Effectiveness and durability of non-nucleoside reverse transcriptase inhibitor-based therapy in HIV clinical practice
Immune reconstitution syndrome in tuberculosis and HIV-co-infected patients: Th1 explosion or cytokine storm?
Atazanavir in plasma-exchange treatment
Partial splenic embolization as a treatment for hypersplenism in HIV/hepatitis C virus-co-infected patients
Response to Morrison et al., ‘Hormonal contraception and the risk of HIV acquisition’
Child sexual abuse, HIV, and tuberculosis in sub-Saharan Africa: a case report from rural Cameroon
Loss of HIV-1-specific T-cell responses associated with very rapid HIV-1 disease progression
Polymorphisms in the 3′ untranslated region of the fractalkine (CX3CL1) gene and the risk of HIV-1 infection and disease progression
Mycobacterium sherrisii: a new opportunistic agent in HIV infection?